.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Novartis
Boehringer Ingelheim
McKinsey
Baxter
UBS
Chubb
Accenture
Covington
Cerilliant

Generated: November 24, 2017

DrugPatentWatch Database Preview

Alectinib hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for alectinib hydrochloride and what is the scope of alectinib hydrochloride patent protection?

Alectinib hydrochloride
is the generic ingredient in one branded drug marketed by Hoffmann-la Roche and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Alectinib hydrochloride has sixty-five patent family members in thirty-six countries and five supplementary protection certificates in four countries.

One supplier is listed for this compound.

Summary for alectinib hydrochloride

Pharmacology for alectinib hydrochloride

Drug ClassKinase Inhibitor
Mechanism of ActionKinase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alectinib hydrochloride

Country Document Number Estimated Expiration
Argentina083246► Subscribe
Japan4588121► Subscribe
South Korea20120034677► Subscribe
Norway2017026► Subscribe
Australia2011291708► Subscribe
Russian Federation2011154150► Subscribe
Colombia6430460► Subscribe
Mexico2011013306► Subscribe
Denmark2441753► Subscribe
EcuadorSP12011573► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ALECTINIB HYDROCHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017017Lithuania► SubscribePRODUCT NAME: ALEKTINIBAS ARBA JO DRUSKA, ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/16/1169 20170216
2017 00024Denmark► SubscribePRODUCT NAME: ALECTINIB, ELLER SALT ELLER SOLVAT DERAF, HERUNDER I FORM AF HYDROCHLORID; REG. NO/DATE: EU/1/16/1169/01 20170220
2017 00024Denmark► SubscribePRODUCT NAME: ALECTINIB, ELLER SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/16/1169/01 20170220
2017000048Germany► SubscribePRODUCT NAME: ALECTINIB ODER EIN SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/16/1169 20170216
0876Netherlands► SubscribePRODUCT NAME: ALECTINIB DAN WEL EEN ZOUT OF SOLVAAT DAARVAN; REGISTRATION NO/DATE: EU/1/16/1169/001 20170220
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Federal Trade Commission
UBS
Express Scripts
Novartis
Farmers Insurance
Merck
QuintilesIMS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot